Two device bigwigs are duking it out at the Supreme Court Tuesday. The outcome of Stryker Corporation v. Zimmer will influence patent cases across multiple industries. The court will rule on Stryker's ($SYK) argument to triple the $70 million it was awarded from Zimmer Biomet ($ZBH) for infringing the patent of one of its devices, the Pulsavac Plus, which is used to clear debris during orthopedic surgery. Here's the Petition for a Writ of Certiorari | Previous coverage from FierceMedicalDevices